Home › Funds › Saratoga Research & Investment Management › JNJ

Saratoga Research & Investment Management position in JNJ

JOHNSON JOHNSON · Health Care

Saratoga Research & Investment Management reported holding 265,132 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$70.2M, representing 3.87% of its reported portfolio and ranking #10 among its reported holdings. Saratoga Research & Investment Management has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)265.13K sh
Reported value held$70.19M
Portfolio Weight3.87%
First reportedQ3 2023
Last changeReduce
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Saratoga Research & Investment Management's JNJ position evolved

Saratoga Research & Investment Management first disclosed a stake in JNJ in Q3 2023 at 456,586 shares (US$71.1M). The position peaked in Q4 2025 at 460,223 shares, worth US$95.2M. Across 13 filings, Saratoga Research & Investment Management increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 265,132 shares valued at US$70.2M — a reduction of -13,327 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2024 (shares rose 11% over the following quarter), a 26% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 456.59K $71.11M New
Q4 2023 435.14K $68.20M Reduce
Q1 2024 439.52K $69.53M Add
Q2 2024 551.75K $80.64M Add
Q3 2024 532.44K $86.29M Reduce
Q4 2024 520.35K $75.25M Reduce
Q1 2025 504.42K $83.65M Reduce
Q2 2025 501.42K $76.59M Reduce
Q3 2025 485.62K $90.04M Reduce
Q4 2025 460.22K $95.24M Reduce
Q1 2026 339.44K $82.97M Reduce
Q2 2026 278.46K $70.72M Reduce
Q3 2026 265.13K $70.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Saratoga Research & Investment Management held JNJ?

Saratoga Research & Investment Management has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Saratoga Research & Investment Management's current position in JNJ?

As of Q3 2026, Saratoga Research & Investment Management holds 265.13K shares of JNJ (JOHNSON JOHNSON), valued at $70.19M, representing 3.87% of its reported portfolio and ranking #10.

Has Saratoga Research & Investment Management been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Saratoga Research & Investment Management reduced its position in JNJ. The position peaked in Q4 2025 at 460.22K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.